Bio-Path Holdings, Inc.
BPTH · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $1,412 | $1 | $2,785 | $2,745 |
| - Cash | $0 | $122 | $1,173 | $562 |
| + Debt | $479 | $315 | $83 | $26 |
| Enterprise Value | $1,891 | $194 | $1,695 | $2,209 |
| Revenue | $0 | $0 | $158 | $0 |
| % Growth | – | -100% | – | – |
| Gross Profit | -$41 | -$32 | $79 | -$33 |
| % Margin | – | – | 50% | – |
| EBITDA | -$4,521 | -$2,815 | -$2,578 | -$2,601 |
| % Margin | – | – | -1,631.6% | – |
| Net Income | -$4,597 | -$2,852 | -$2,753 | -$2,115 |
| % Margin | – | – | -1,742.4% | – |
| EPS Diluted | -0.55 | -0.4 | -1.15 | -0.7 |
| % Growth | -37.5% | 65.2% | -64.3% | – |
| Operating Cash Flow | -$283 | -$1,313 | -$2,881 | -$3,428 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$283 | -$1,313 | -$2,881 | -$3,428 |